
Understanding Beta-Thalassemia Major: A Genetic Perspective
Genetic testing uncovers mutations in beta-thalassemia major, enabling precise diagnosis, personalized treatments, and informed reproductive decisions for better care.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Genetic testing uncovers mutations in beta-thalassemia major, enabling precise diagnosis, personalized treatments, and informed reproductive decisions for better care.

Explore the impact of genetic testing on diagnosing BPIDS. Learn how it aids in accurate diagnosis, early intervention, and guides family planning effectively.

Explore the role of genetic testing in diagnosing and managing Bruck syndrome, a rare disorder, uncovering insights into FKBP10 gene variations for personalized care.

Genetic testing empowers Caudal Regression Sequence diagnosis by revealing genetic causes, guiding personalized treatment, and supporting effective genetic counseling.

Unlock new insights into choroid plexus carcinoma with genetic testing. Explore the impact of genetic mutations and precision medicine on treatment outcomes.

Explore the genetic basis of Citrin Deficiency, its symptoms, and how genetic testing offers early diagnosis, personalized treatment, and informed family planning.

Genetic testing confirms Citrullinemia Type II, informs family planning, and guides dietary changes, optimizing care for this rare metabolic disorder.

Explore how genetic testing improves early detection, personalized treatment, and prognosis in Combined Pulmonary Fibrosis-Emphysema Syndrome for better care.